NCT05834595View on ClinicalTrials.gov

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

July 18, 2023

Study Completion Date

July 26, 2023

Conditions
Hypertension
Interventions
DRUG

CKD-828, D064, D701

QD, PO

Trial Locations (1)

15079

Central hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY